# Veterans Affairs Clinical Resource Hubs and Rates of Mental Health Community Care Referrals

**Authors:** Samantha L. Connolly, Erin L. Jaske, Chelle Wheat, Lawrence J. Wahlberg, Karin Nelson, Idamay Curtis, Bradford Felker

PMC · DOI: 10.1001/jamanetworkopen.2025.60084 · JAMA Network Open · 2026-02-27

## TL;DR

This study finds that VA clinics using mental health resource hubs have fewer referrals to community care, suggesting better access to care within the VA system.

## Contribution

The study demonstrates that higher use of VA Clinical Resource Hubs is associated with reduced reliance on community care referrals for mental health.

## Key findings

- Clinics with high Clinical Resource Hub (CRH) utilization had 20 fewer community care referrals per 1000 patients per month.
- Successful CRH implementation is linked to decreased reliance on VA-purchased community care for mental health services.

## Abstract

This cohort study reports on the association of veterans’ use of Department of Veterans Affairs’ Clinical Resource Hubs for mental health care with the number of referrals to community care.

Is increased use of Clinical Resource Hubs (CRHs) associated with decreased referrals to community care (CC) for mental health care within the US Department of Veterans Affairs (VA)?

In this cohort study of 1149 mental health clinics within the VA, clinics with greater use of CRHs had a mean of 20 fewer referrals to CC per 1000 patients per month.

Results of this study suggest that successful CRH implementation is associated with fewer CC referrals and that clinics with higher CRH utilization become less reliant on VA-purchased CC.

In an effort to increase access to care, the US Department of Veterans Affairs (VA) has created 2 additional pathways for veterans to receive mental health (MH) services: regional VA Clinical Resource Hubs (CRHs) and VA-purchased community care (CC). Previous studies have found that veterans rate their satisfaction with VA MH care, including via CRHs, higher than CC. It is unclear whether increased CRH use decreases referrals to CC.

To determine whether clinics with higher CRH utilization have fewer CC referrals or, alternatively, whether clinics with local care shortages rely on both CRH and CC at similar levels to ensure adequate access to MH care.

This longitudinal cohort study included all veterans with at least 1 outpatient MH encounter between 2018 and 2019 in 1149 MH clinics within the VA. The study evaluated changes in CC referral rates at clinics with and without CRH visits between baseline and post-CRH implementation (October 1, 2017, through September 30, 2023). In addition, CC referral rates at clinics with higher use of CRH were compared with clinics with lower CRH utilization. Data were analyzed from August 20, 2024, to July 25, 2025.

Clinics were classified based on whether they had any CRH utilization, as well as whether their per-patient rate of CRH visits fell in the top 25% (high penetration) or bottom 25% (low penetration).

The main outcome was the number of CC referrals per 1000 patients. Difference-in-differences (DID) analyses were used.

The sample included 1 120 250 patients (mean [SD] age, 60.04 [15.38] years; 15.99% female). Clinics with any CRH utilization showed a slight but statistically significant increase in CC referrals in the post-CRH implementation period compared with clinics with no CRH utilization (DID, 0.525; 95% CI, 0.181-0.868; P = .003). However, clinics with high penetration of CRH had fewer CC referrals per month compared with low-penetration clinics at the end of the CRH implementation period (DID, –20.00 referrals; 95% CI, –21.90 to –18.20; P < .001).

In this cohort study of VA MH clinics, successful CRH implementation was associated with fewer CC referrals, suggesting that clinics with higher CRH utilization were less reliant on VA-purchased CC. Results underscore the importance of developing strong CRH infrastructures to ensure veteran access to high-quality MH care.

## Full-text entities

- **Genes:** CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}
- **Diseases:** PTSD (MESH:D013313), substance use disorder (MESH:D019966), schizophrenia (MESH:D012559), depression (MESH:D003866), bipolar disorder (MESH:D001714), COVID-19 (MESH:D000086382), ADHD (MESH:D001289), MH (OMIM:603663), Mental (MESH:D008607)
- **Chemicals:** cobalt (MESH:D003035), CC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949438/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949438/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949438/full.md

---
Source: https://tomesphere.com/paper/PMC12949438